UncategorizedIllumina doubles down on multiomics with $350m SomaLogic acquisition Empower Meds / November 21, 2025
UncategorizedDigital biomarkers of aging move toward clinical credibility Empower Meds / November 21, 2025
UncategorizedIllumina to acquire SomaLogic for $350 million – Longevity.Technology Empower Meds / November 21, 2025
UncategorizedInfinity Bio lands funding to harness the ‘reactome’ against disease Empower Meds / November 21, 2025
UncategorizedCoronary laser takes aim at calcified arteries in aging patients Empower Meds / November 21, 2025
UncategorizedStartup introduces multi-organ biological age test for women Empower Meds / November 21, 2025
UncategorizedPrize aims to drive AI into the heart of ALS drug discovery Empower Meds / November 21, 2025
UncategorizedOutSee lands funding to harness predictive genomics in drug discovery Empower Meds / November 21, 2025
